Dr. Shankara Paneesha discussed the evolving treatment landscape for relapsed CLL, focusing on BTK resistance, new treatment options including cellular therapy, and the importance of patient-specific factors in treatment decisions.
Please complete the brief questionnaire below to unlock the video. After watching, answer a few more questions to receive your CME certificate, which you can save, download, or print. This video covers the topic of diagnostic markers in CLL and is CME accredited for 0.25 credits (15 min). 0:00 – Introduction by Julio Delgado, head
This site is only for use by healthcare professionals.
By continuing to view this site you are confirming that you are a healthcare professional.
Confirm